Stay tuned for more information about this event on October 13th! http://tedxleamingtonspa.com/2018-event/
https://www.termis.org/wc2018/ On September 7th, CSO speaks about monogenic disease modeling using NuHeart™ technology during TERM for heart, blood vessel & lung session. 99-O-5: Personalized micro-3D human heart tissues for orphan drug development Tetsuro Wakatsuki，Neil Daily，Pinar Kemanli， Michael Greenberg，Jennifer Strande InvivoSciences, Inc. Madison Wisconsin, USA, Washington University, St. Louis, Medical College of Wisconsin.
InvivoSciences, Inc. is collaborating with Drs. Elson and Qian to establish a novel mathematical model to understand the development of cardiac fibrosis during heart failure. The model will be used to identify and validate new therapeutic targets to prevent, slow, or reverse cardiac fibrosis. https://www.sciencedirect.com/science/article/pii/S0079610718301135
Recent Comments